Aptevo Therapeutics Inc. Current Income Tax Expense (Benefit)
Aptevo Therapeutics Inc. (APVO) reported Current Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-26
- Aptevo Therapeutics Inc. current income tax expense (benefit) for fiscal 2025 was $0.00.
- Aptevo Therapeutics Inc. current income tax expense (benefit) for fiscal 2024 was $0.00.
- Aptevo Therapeutics Inc. current income tax expense (benefit) for fiscal 2023 was $0.00.
- Aptevo Therapeutics Inc. current income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-14 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-05 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-25 | |
| 2017-12-31 | -$12.76M 10-K · filed 2019-03-18 | |
| 2016-12-31 | -$4.50M 10-K · filed 2018-03-13 | -$29.00K 10-K · filed 2017-03-31 |
| 2015-12-31 | -$660.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |